CAJ | 학술논문

[目的]探讨结膜瓣遮盖联合睑裂缝合术予规范化药物治疗难治性角膜溃疡的疗效。[方法]选取2007年5月至2013年7月本院住院并诊断为难治性角膜溃疡患者37例37眼，将其分为对照组17例17眼、观察组20例20眼，对照组实施结膜瓣遮盖联合睑裂缝合术及常规药物治疗，观察组实施结膜瓣遮盖联合睑裂缝合术及规范化药物治疗干预，术后6个月复诊观察疗效。[结果]观察组治愈18例（占90%），好转2例(占10%)，对照组治愈9例（占52.9%），好转4例（占23.5%），无效4例（占23.5%），两组总疗效比较，差异有统计学意义（P＜0.05）。[结论]结膜瓣遮盖联合睑裂缝合术治疗难治性角膜溃疡，予规范化药物治疗干预，能明显提高手术疗效。
[목적]탐토결막판차개연합검렬봉합술여규범화약물치료난치성각막궤양적료효。[방법]선취2007년5월지2013년7월본원주원병진단위난치성각막궤양환자37례37안，장기분위대조조17례17안、관찰조20례20안，대조조실시결막판차개연합검렬봉합술급상규약물치료，관찰조실시결막판차개연합검렬봉합술급규범화약물치료간예，술후6개월복진관찰료효。[결과]관찰조치유18례（점90%），호전2례(점10%)，대조조치유9례（점52.9%），호전4례（점23.5%），무효4례（점23.5%），량조총료효비교，차이유통계학의의（P＜0.05）。[결론]결막판차개연합검렬봉합술치료난치성각막궤양，여규범화약물치료간예，능명현제고수술료효。
[Objective] To discuss the cure effect of conjunctiva valve combined with tarsorrhaphy and standardized medication on refractory keratohelcosis. [Method] Choose 37 cases with 37 eyes of the disease above, divide them into control group, n=17, and observation group, n=20; the control one take conjunctiva valve combined with tarsorrhaphy and routine medicine intervention; other group, standardized drug intervention instead of routine medicine. Observe the therapeutic effect after 6m. [Result] In observation group, 18 cases were cured(90%), 2 better(10%); for other group, they were 9(52.9%) and 4(23.5%) respectively, and 4 cases had no effect(23.5%). Comparing both cure effects, the difference had statistical meaning. [Conclusion] The conjunctiva valve combined with tarsorrhaphy could markedly improve the cure effect if intervened with standardized drug.